Compare TEVA & KEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | KEYS |
|---|---|---|
| Founded | 1901 | 1939 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 29.8B |
| IPO Year | N/A | N/A |
| Metric | TEVA | KEYS |
|---|---|---|
| Price | $31.87 | $206.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $32.11 | ★ $215.45 |
| AVG Volume (30 Days) | ★ 10.3M | 1.2M |
| Earning Date | 01-28-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.89 |
| EPS | 0.62 | ★ 4.91 |
| Revenue | ★ $16,776,000,000.00 | $5,375,000,000.00 |
| Revenue This Year | $4.62 | $16.56 |
| Revenue Next Year | $0.34 | $6.30 |
| P/E Ratio | $51.43 | ★ $41.82 |
| Revenue Growth | 0.02 | ★ 7.95 |
| 52 Week Low | $12.47 | $121.43 |
| 52 Week High | $31.99 | $214.58 |
| Indicator | TEVA | KEYS |
|---|---|---|
| Relative Strength Index (RSI) | 85.04 | 61.34 |
| Support Level | $28.00 | $202.00 |
| Resistance Level | $31.99 | $207.58 |
| Average True Range (ATR) | 0.61 | 4.43 |
| MACD | 0.02 | -1.21 |
| Stochastic Oscillator | 95.37 | 55.53 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.